标题
Frequent aneuploidy in primary human T cells after CRISPR–Cas9 cleavage
作者
关键词
-
出版物
NATURE BIOTECHNOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-07-01
DOI
10.1038/s41587-022-01377-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- HLA-independent T cell receptors for targeting tumors with low antigen density
- (2022) Jorge Mansilla-Soto et al. NATURE MEDICINE
- Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
- (2021) Mitchell L. Leibowitz et al. NATURE GENETICS
- CRISPR–Cas9 can cause chromothripsis
- (2021) Fyodor D. Urnov NATURE GENETICS
- CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells
- (2021) J. Boutin et al. Nature Communications
- Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing
- (2021) Stamatis Papathanasiou et al. Nature Communications
- The long road to the first FDA-approved gene therapy: chimeric antigen receptor T cells targeting CD19
- (2020) Peter Braendstrup et al. CYTOTHERAPY
- Unintended on-target chromosomal instability following CRISPR/Cas9 single gene targeting
- (2020) J. Przewrocka et al. ANNALS OF ONCOLOGY
- The Emerging Landscape of Immune Cell Therapies
- (2020) Evan W. Weber et al. CELL
- Determining the impact of uncharacterized inversions in the human genome by droplet digital PCR
- (2020) Marta Puig et al. GENOME RESEARCH
- Cas9 activates the p53 pathway and selects for p53-inactivating mutations
- (2020) Oana M. Enache et al. NATURE GENETICS
- Detection of Deleterious On-Target Effects after HDR-Mediated CRISPR Editing
- (2020) Isabel Weisheit et al. Cell Reports
- Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
- (2020) Andrew V. Anzalone et al. NATURE BIOTECHNOLOGY
- CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity
- (2020) Cicera R. Lazzarotto et al. NATURE BIOTECHNOLOGY
- Promoterless, nuclease‐free genome editing confers a growth advantage for corrected hepatocytes in mice with methylmalonic acidemia
- (2020) Randy J. Chandler et al. HEPATOLOGY
- Allele-Specific Chromosome Removal after Cas9 Cleavage in Human Embryos
- (2020) Michael V. Zuccaro et al. CELL
- Engineered B cells expressing an anti-HIV antibody enable memory retention, isotype switching and clonal expansion
- (2020) Alessio D. Nahmad et al. Nature Communications
- Identification of preexisting adaptive immunity to Cas9 proteins in humans
- (2019) Carsten T. Charlesworth et al. NATURE MEDICINE
- Comprehensive Integration of Single-Cell Data
- (2019) Tim Stuart et al. CELL
- Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
- (2019) Kilian Schober et al. Nature Biomedical Engineering
- Context is everything: aneuploidy in cancer
- (2019) Uri Ben-David et al. NATURE REVIEWS GENETICS
- Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
- (2019) Beau R. Webber et al. Nature Communications
- Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements
- (2018) Michael Kosicki et al. NATURE BIOTECHNOLOGY
- Large deletions induced by Cas9 cleavage
- (2018) Fatwa Adikusuma et al. NATURE
- Reprogramming human T cell function and specificity with non-viral genome targeting
- (2018) Theodore L. Roth et al. NATURE
- Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function
- (2018) Eric Shifrut et al. CELL
- Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
- (2017) Daniel T. MacLeod et al. MOLECULAR THERAPY
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
- (2017) Waseem Qasim et al. Science Translational Medicine
- CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
- (2017) Levi J. Rupp et al. Scientific Reports
- Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases
- (2016) Mark J Osborn et al. MOLECULAR THERAPY
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
- (2016) I. Tirosh et al. SCIENCE
- Selective advantage of trisomic human cells cultured in non-standard conditions
- (2016) Samuel D. Rutledge et al. Scientific Reports
- Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies
- (2015) Laurent Poirot et al. CANCER RESEARCH
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination Immunotherapy
- (2015) Julien Valton et al. MOLECULAR THERAPY
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
- (2014) A. Barzel et al. NATURE
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started